In summary, we found no significant difference between species in glucose change response to either DPP4 inhibitor, possibly suggesting that studies in mouse and rats models of T2DM are equally useful in predicting drug effects in humans. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.